Locked price vs escalating price
TMates vs He & She MD: Which Price Survives Titration? (2026)
TMates or He & She MD? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.0 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between TMates and He & She MD usually comes down to one difference that neither homepage puts in its headline.
GLP-1 dosing escalates over the first few months, and providers differ on whether the invoice escalates with it. TMates holds one rate at every dose; He & She MD's price moves from $139 to $191.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Anything a provider declines to disclose is marked undisclosed rather than filled in.
The short answer
- Lowest 12-month cost
- He & She MD — $1,980 against $2,388 at TMates, on each provider's own best published pricing.
- Most predictable bill
- TMates — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- He & She MD — Tirzepatide at $199/mo; the other side publishes semaglutide only.
- Easiest to pay for
- TMates — Neither publishes financing; both expect the full amount monthly.
TMates vs He & She MD at a glance
The rows below are the ones that differ enough between these two to be worth your attention.
| TMates | He & She MD | |
|---|---|---|
| Advertised price | $199/mo at every dose, no step-up fees | Semaglutide from $139/mo, oral semaglutide and tirzepatide from $199/mo |
| Rate after promotions | $199/mo | $191/mo |
| Pricing structure | Flat rate at every dose | Introductory term, then renewal at a higher rate |
| Medication | Compounded semaglutide | Compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | Virtual check-in appointments | 2-3 minute intake with no payment required to check eligibility |
| State coverage | All 50 states | Not published |
| Patient reviews | 21,970 | 4,180 |
| eRxDoctor score | 7.0/10 | 7.0/10 |
TMates vs He & She MD on total cost, not entry price
Comparing entry prices across these two would be actively misleading, because they escalate differently. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| TMates | He & She MD | |
|---|---|---|
| First month | $199 | $139 |
| Months 2 onward | $199/mo | $191/mo |
| 6-month total | $1,194 | $834 |
| 12-month total | $2,388 | $1,980 |
| Best published plan | No multi-month discount published | No multi-month discount published |
He & She MD finishes the year $408 cheaper. For some patients the support TMates bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: He & She MD moves from $139 to $191, a 37% increase. Set a calendar reminder for the month it changes.
What happens to the price as your dose goes up
Semaglutide and tirzepatide are titrated upward over the first months of treatment. Some providers price per milligram in all but name, so the invoice climbs alongside the dose; others hold one rate the whole way.
TMates is in the second group: one flat $199 that survives every titration step, with doctors rather than a message queue behind it. He & She MD is in the first — the headline rates are six-month terms that renew 30-45% higher — which means the number you compared at signup is not the number you will be paying at month four.
This is the single most common way people end up paying more than they planned for GLP-1 treatment. It is also the easiest to check: ask what the highest maintenance dose costs, not what the starting dose costs.
TMates: what you are buying
TMates positions itself on one flat $199 that survives every titration step, with doctors rather than a message queue behind it. $199/month, every dose, no step-up fees
Practically: virtual check-in appointments, medication formulated in U.S. facilities, and a pricing model that is flat rate at every dose.
On the clinical side, 24/7 access to U.S.-based doctors, not just messaging, prescribing compounded semaglutide.
TMates pros
- Virtual check-in appointments for ongoing medical oversight
- Flat $199/month at every dose, no step-up fees as dosage escalates
- 24/7 access to U.S.-based doctors, not just messaging support
- Licensed coverage in all 50 states
TMates cons
- Compounded semaglutide only, limited public detail on tirzepatide availability
- $199/month is higher than the cheapest compounded options
- No branded Ozempic, Wegovy, or Zepbound
The reservation worth holding, particularly next to He & She MD: semaglutide only, and $199 is well above the cheapest compounded options.
A closer look at He & She MD
He & She MD bundles compounded GLP-1 medication with a coaching app that carries 1:1 clinician messaging, GLP-1-specific guidance and progress tracking. Semaglutide injections start at $139/month, oral semaglutide and tirzepatide at $199/month, each a six-month introductory rate. Free expedited shipping, no membership fee, no insurance required. Against TMates, that puts it in the position of the cheaper option.
From signup to first shipment: 2-3 minute intake with no payment required to check eligibility, then free expedited shipping with no upcharges. Billing follows a introductory term, then renewal at a higher rate structure.
Behind the prescription sits coaching app with 1:1 clinician messaging and progress tracking, no extra charge. Available medication: compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.
He & She MD pros
- Fast 2-3 minute intake with no payment required to check eligibility
- Three formats: semaglutide injection, oral semaglutide, tirzepatide injection
- Coaching app, 1:1 clinician messaging and progress tracking included at no extra cost
- Named, dual board-certified obesity-medicine Chief Medical Officer
He & She MD cons
- Headline prices are 6-month intro rates that renew 30-45% higher
- Pricing is structured as six-month terms, not true month-to-month
- Compounded GLP-1s are not reviewed by the FDA for safety, efficacy or quality
Read next to TMates, the weak point: the headline rates are six-month terms that renew 30-45% higher.
Picking between them
Choose TMates if:
- you want the price you sign up at to survive titration
- you would rather use the platform with the longer public record (21,970 reviews)
- you are in a state where GLP-1 telehealth coverage is patchy
- you would get real value from one flat $199 that survives every titration step, with doctors rather than a message queue behind it
Choose He & She MD if:
- delivery works the way you want it to: free expedited shipping with no upcharges
- you want to start on their timeline: 2-3 minute intake with no payment required to check eligibility
- the level of clinical contact suits you: coaching app with 1:1 clinician messaging and progress tracking, no extra charge
- the feature you would actually use: three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO
The trade-offs, stated plainly
On price. He & She MD is the cheaper program at $191/mo against $199/mo. What He & She MD gives up for that is the headline rates are six-month terms that renew 30-45% higher; what TMates charges for is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. TMates provides 24/7 access to U.S.-based doctors, not just messaging. He & She MD provides coaching app with 1:1 clinician messaging and progress tracking, no extra charge. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. TMates covers compounded semaglutide; He & She MD covers compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection. Only He & She MD publishes a tirzepatide route, which matters if semaglutide underdelivers.
What the trials and the FDA say
Neither TMates nor He & She MD manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
TMates vs He & She MD: common questions
Which is cheaper to start, TMates or He & She MD?
He & She MD, at $139 against $199. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Does the price go up as my dose increases?
At TMates, no — one flat $199 that survives every titration step, with doctors rather than a message queue behind it. At He & She MD, the published structure is introductory term, then renewal at a higher rate, moving from $139 to $191. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
What happens if I stop taking the medication?
Neither TMates nor He & She MD penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Are TMates and He & She MD legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. TMates operates on flat rate at every dose with pricing published upfront, He & She MD on introductory term, then renewal at a higher rate, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
Can I switch from TMates to He & She MD later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date.
Is TMates or He & She MD better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis TMates has the stronger case; after month three, cost should take over.
The verdict
He & She MD is the cheaper year by $408, and for a straightforward course of treatment that settles it.
TMates earns the difference in one situation: when one flat $199 that survives every titration step, with doctors rather than a message queue behind it is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Yucca Health vs TMatesTirzepatide access
- TrimRx vs TMatesTirzepatide access
- Novi vs He & She MDCoaching-supported vs medication-only
- Mochi Health vs He & She MDBudget vs premium
- IVIM Health vs LIV BodyLocked price vs escalating price
- IVIM Health vs TMatesLocked price vs escalating price
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by TMates or He & She MD, and does not sell treatment. Read our ranking methodology.